Literature DB >> 8355256

Peptidomimetic HIV protease inhibitors: phosphate prodrugs with improved biological activities.

K T Chong1, M J Ruwart, R R Hinshaw, K F Wilkinson, B D Rush, M F Yancey, J W Strohbach, S Thaisrivongs.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8355256     DOI： 10.1021/jm00069a018

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  3 in total

Review 1.  Antiviral therapy for human immunodeficiency virus infections.

Authors:  E De Clercq
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

2.  Bisheteroarylpiperazine reverse transcriptase inhibitor in combination with 3'-azido-3'-deoxythymidine or 2',3'-dideoxycytidine synergistically inhibits human immunodeficiency virus type 1 replication in vitro.

Authors:  K T Chong; P J Pagano; R R Hinshaw
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

3.  Synthesis and Characterization of Long-Acting Darunavir Prodrugs.

Authors:  Mary G Banoub; Aditya N Bade; Zhiyi Lin; Denise Cobb; Nagsen Gautam; Bhagya Laxmi Dyavar Shetty; Melinda Wojtkiewicz; Yazen Alnouti; JoEllyn McMillan; Howard E Gendelman; Benson Edagwa
Journal:  Mol Pharm       Date:  2019-12-03       Impact factor: 4.939
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.